“…Increased uptake of Se-75 SM has been reported in various tumors such as lymphoma, hepatoma, metastatic melanoma to liver, islet cell tumor, thyroid carcinoma, parathyroid adenoma, thymoma, seminoma, and chondrosarcoma [6,8], In lymphoma patients given Se-75 SM, Ben-Porath el al. ob served more rapid disappearance of the activity from the blood, as opposed to the controls [10], FERRUCI et al reported that abnormal scintigraphy indicated a 70-80% likelihood that disease was present in 33 lymphoma patients [8], It has also been stated that Se-75 SM, while not specific for lymphomas, appeared worthy for further evaluation in following the course and distribution of lymphomas [11], H e r r e r a el al.…”